CNL Continues to Attract World’s Best &

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
105
CNL Continues to Attract World’s Best & Brightest Nuclear Scientists and Engineers

CHALK RIVER, Ontario, May 10, 2018 (GLOBE NEWSWIRE) -- Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear science and technology organization, is pleased to announce that it has hired over 100 new scientists, engineers and other technical professionals from around the world as part of its recruitment campaign to foster the continued growth of its nuclear science and technology products and services. The hiring is to support CNL’s Long-Term Strategy, an ambitious 10-year plan that will position the organization as a global leader in nuclear science and technology, and a period during which CNL’s research staffing is projected to grow by more than 20 per cent.

CNL intends to develop a variety of new products and services as part of its transformation, including the deployment of small modular reactors, the pursuit of commercial opportunities in targeted alpha therapies, and the use of hydrogen to decarbonise Canada’s transportation sector. In order to prepare for this organizational transition, CNL established a human resources strategy last year to ensure that it has the high-calibre workforce needed to grow and expand CNL’s science and technology programs.

“The revitalization of the Chalk River Laboratories campus is an exciting time for CNL, with the construction of new, world-class facilities, the modernization of the site’s infrastructure, and the development of ambitious new research programs. But this transition extends to our people as well,” commented Mark Lesinski, CNL’s President and CEO. “We are working hard to attract new talent, and to grow and retain the talent we have here already, to develop and deliver the innovative nuclear products, technologies and services of tomorrow. So far, that process is going very well.”

The permanent shut down of NRU created an opportunity to retain the talent CNL already has, and to redeploy hundreds of staff into new positions within the company in support of its renewed science and research programs. Many vacancies, particularly in CNL’s research programs, remain. In response, CNL refocused its recruitment efforts to attract high-quality talent globally to augment its existing team.

With the recent hiring of over 100 new research personnel, and ongoing interactions with talented candidates, CNL’s effort has proven very successful. The new additions to CNL’s research programs include international expertise in a variety of disciplines, including nuclear physics, fuels and materials for light water reactors, hydrogeology, cyber security, metallography, molecular and cell biology, data science, and high temperature heat transfer engineering.

“CNL’s research staff embody our science and technology capabilities, and so we are absolutely thrilled that we’ve been able to attract these high-calibre employees to CNL through this focused recruitment,” explained Kathy McCarthy, Vice-President of Research and Development. “We have a very ambitious vision for the future of our organization, but we need the right people to bring this vision to life. Through this campaign, we’ve taken an important step towards that objective.”

Over the coming year, CNL will continue to work to attract new talent to fill remaining vacancies in its R&D organization and other business areas. CNL’s recruitment specialists will be visiting colleges and universities across Canada and the US, as well as career fairs, industry events and strengthening the online recruitment materials and job postings. For more information on working at Canadian Nuclear Laboratories, to review the human resources strategy or to apply to vacancies, please visit www.cnl.ca .

About CNL

Canadian Nuclear Laboratories is a world leader in nuclear science and technology offering unique capabilities and solutions across a wide range of industries. Actively involved with industry-driven research and development in nuclear, transportation, clean technology, energy, defence, security and life sciences, we provide solutions to keep these sectors competitive internationally.

With ongoing investments in new facilities and a focused mandate, Canadian Nuclear Laboratories is well positioned for the future. A new performance standard reinforced with a strong safety culture underscores every activity.

For more information on the complete range of Canadian Nuclear Laboratories services, please visit www.cnl.ca or contact communications@cnl.ca .

Contact: Patrick Quinn Director, Corporate Communications CNL, 1-866-886-2325

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles